Rosacea Review - Newsletter of the National Rosacea SocietyRosacea Review - Newsletter of the National Rosacea Society


Common Acid Suppressants May Increase Risk of Rosacea, New Study Suggests

A new study from South Korea links the use of acid suppressants – proton pump inhibitors (PPIs) and histamine-2 receptor antagonists (H2RAs), widely used therapies for treatment of acid-related gastrointestinal diseases such as peptic ulcer disease, heartburn, gastroesophageal reflux disease (GERD) and others – and increased risk of rosacea, according to a recent report in the Journal of Korean Medical Science.1

Rosacea Potentially Linked To Eye Diseases

Editor's Note: It’s important to note that findings of comorbidity studies like this one only suggest a potential association. To determine any cause and effect relationship, further study is required.

Several eye diseases, including the potentially blinding glaucoma, are now among the many serious systemic disorders that have been found to occur more often in individuals with rosacea, according to recent separate studies in Taiwan and South Korea.

Research May Add to Ocular Rosacea Therapy Choices

While avoidance of trigger factors, gentle cleansing and a variety of medical therapies are among today’s options for controlling ocular rosacea, continuing research on its pathophysiology is uncovering potential avenues for the development of important new advances in its treatment, according to Dr. Edward Wladis, associate professor and vice-chairman of ophthalmology at Albany Medical College, in a recent article in the medical journal Survey of Ophthalmology.1

Subscribe to research